Intuitive Surgical shares soared after the surgical robot maker posted earnings that topped expectations. Major U.S. equities indexes slid Wednesday afternoon after a flurry of weaker-than-expected ...
Barchart on MSN
Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.
Kenvue (KVUE) could really use some good news. The Johnson & Johnson (JNJ) spinoff faced longlasting troubles regarding its ...
Perimenopausal women who used estrogen for at least 10 years before their periods stopped had 60% lower odds for breast ...
Kenvue, the maker of Tylenol, is urging U.S. health regulators not to add an autism warning label to it and other ...
The maker of Tylenol is urging U.S. health regulators not to add an autism warning label to it and other pain-relievers ...
Kenvue, the maker of Tylenol, opposes proposed changes to the product's safety label regarding potential links to autism and ...
The U.S. Food and Drug Administration (FDA) has classified the recall of Neutrogena Makeup Remover Ultra-Soft Cleansing ...
Tylenol maker Kenvue is calling on the Food and Drug Administration (FDA) to back off a proposed safety label change to ...
Kenvue, the owners of Tylenol, are pushing back on claims that acetaminophen—the chemical compound in their popular ...
Kenvue Inc's (NYSE: KVUE) short interest as a percent of float has fallen 20.2% since its last report. According to exchange reported data, there are now 34.24 million shares sold short, which is 2.37 ...
Kenvue stock drops 30% YTD, but Starboard's Jeff Smith remains optimistic, citing leadership changes and brand improvements.
Tylenol's maker is pushing back against proposed safety label changes that would include autism-related pregnancy warnings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback